 |
|
Human chorionic gonadotropin therapy in hypogonadic severe-oligozoospermic men and its effect on semen parameters
Syed Waseem Andrabi, Giresh Chandra Makker, Renu Makker, Geetanjali Mishra, Rajender Singh
Clin Exp Reprod Med. 2022;49(1):57-61. Published online 2022 Feb 28 DOI: https://doi.org/10.5653/cerm.2021.04742
|
|
Citations to this article as recorded by
 Recuperación de la espermatogénesis tras el abuso de esteroides anabólicos androgénicos en varones. Revisión sistemática de la literatura
O. Rajmil, J. Moreno-Sepulveda
Actas Urológicas Españolas.2024; 48(2): 116. CrossRef Recovery of spermatogenesis after androgenic anabolic steroids abuse in men. A systematic review of the literature
O. Rajmil, J. Moreno- Sepulveda
Actas Urológicas Españolas (English Edition).2024; 48(2): 116. CrossRef APHRODITE criteria: addressing male patients with hypogonadism and/or infertility owing to altered idiopathic testicular function
Sandro C. Esteves, Peter Humaidan, Filippo M. Ubaldi, Carlo Alviggi, Leen Antonio, Christopher L.R. Barratt, Hermann M. Behre, Niels Jørgensen, Allan A. Pacey, Manuela Simoni, Daniele Santi
Reproductive BioMedicine Online.2024; 48(4): 103647. CrossRef A Case Study Based on the Effect of Phytoestrogen on an Oligozoospermic Patient
Ritesh Jadhav, Akash More, Namrata Choudhary, Jarul Shrivastava, Shilpa Dutta, Gauri Gajabe, Saurabh Mehakar
Cureus.2024;[Epub] CrossRef Male infertility and gonadotropin treatment: What can we learn from real-world data?
Sandro C. Esteves, Arnold P.P. Achermann, Manuela Simoni, Daniele Santi, Livio Casarini
Best Practice & Research Clinical Obstetrics & Gyn.2023; 86: 102310. CrossRef
|